J.P. Morgan Private Wealth Advisors LLC - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 39 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q1 2022$26,000
-18.8%
31,7200.0%0.00%
Q4 2021$32,000
-22.0%
31,7200.0%0.00%
Q3 2021$41,000
+57.7%
31,720
+5.7%
0.00%
Q2 2019$26,000
-21.2%
30,0000.0%0.00%
Q1 2019$33,000
+83.3%
30,0000.0%0.00%
Q4 2018$18,000
-35.7%
30,0000.0%0.00%
Q3 2018$28,000
+115.4%
30,0000.0%0.00%
Q2 2018$13,000
-43.5%
30,0000.0%0.00%
Q1 2018$23,000
-42.5%
30,0000.0%0.00%
Q3 2017$40,00030,0000.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Alliance Wealth Management Group 400,826$465,0000.23%
Yellowstone Partners, LLC 143,914$167,0000.09%
IFP Advisors, Inc 251,172$291,0000.01%
HYMAN CHARLES D 79,800$93,0000.01%
Virtu Financial LLC 106,146$123,0000.01%
Raymond James Financial Services Advisors, Inc. 659,890$765,0000.01%
Tower Research Capital LLC (TRC) 21,181$25,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 189,000$219,0000.00%
BlackRock Inc. 2,530,508$2,935,0000.00%
Bank of New York Mellon Corp 175,325$203,0000.00%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders